Hillcrest Clinical Research   Report issue

For profit Phase 3
Founded: Oklahoma City OK United States (2005)

Organization Overview

First Clinical Trial
2013
NCT01887678
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (2)

traumeel (1 trial)

zeel (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Osteoarthritis (Phase 3)

Osteoarthritis, Knee (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 2